| NDAQ |
Report |
Non-GAAP diluted EPS |
BEAT |
pred ~$1.00 vs. cons $0.97 |
MEDIUM |
| NDAQ |
Report |
Net revenue |
BEAT |
pred ~$1.46B vs. cons $1.43B |
MEDIUM |
| NDAQ |
Report |
Financial Technology revenue |
BEAT |
pred ~$548M vs. cons $538M |
MEDIUM |
| NDAQ |
Guide |
FY26 non-GAAP operating-expense guidance |
UNCHANGED |
guide ~$2.515B midpoint vs. cons $2.515B midpoint (FY26) |
HIGH |
| NDAQ |
Guide |
FY26 non-GAAP tax-rate guidance |
UNCHANGED |
guide ~23.5% midpoint vs. cons 23.5% (FY26) |
HIGH |
| NDAQ |
Guide |
Financial Technology organic growth commentary |
BETTER |
guide ~16% organic growth vs. cons 15% (2H26) |
MEDIUM |
| NDAQ |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| NDAQ |
Return |
5-day cumulative residual |
+5.5% (FOLLOW-THROUGH) |
Day-1 residual ~3.5% vs. a modeled 0.0% benchmark; 5-day residual ~5.5% vs. the same 0.0% benchmark. A revenue/EPS beat led by Financial Technology, plus sustained mid-teens organic-growth commentary and unchanged FY26 expense guidance, should lift 2026-27 revenue and EPS estimates rather than create a one-quarter, market-services-driven beat. |
MEDIUM |